Tag: cancer
-
Nanotech Crispr Delivery in Development
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment.
-
Moderna Funding University Immunology Research
A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders.
-
Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-
Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.
-
Gel, Crispr Help Defeat Cancer Drug Obstacles
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells.
-
Response by Patients Shown to Precision Lung Cancer Drug
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition.
-
Urine Test Shows Promise for Cancer Screening
Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer.
-
Patch Designed for Vaccines, Cancer Treatments
An engineering team designed a small skin patch with tiny needles that in lab mice quickly delivers vaccines and possibly treatments for melanoma.
-
Controlled Brain Tumor Gene Therapy Shown Safe
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer.
-
MD Anderson, Drug Maker Partner on Lung, GI Cancers
MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers.